Home > Press > Nanomix Receives Patent for Sensation Detection Technology
Devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules
Nanomix Receives Patent for Sensation Detection Technology
May 24, 2005
Nanomix Incorporated, a leading nanotechnology company commercializing nanoelectronic detection devices for industrial and biomedical applications, announced today the issuance of a U.S. patent for its nanostructured detection platform known as Sensation.
The patent includes broad claims related to nanostructured detection devices. These devices harness unique features enabled by nanoelectronics resulting in ultra-sensitive, accurate and selective measurement of chemicals and bio molecules. The devices have extremely low power requirements and are scalable for mass production in a variety of product applications.
"We are pleased with our emerging patent portfolio related to nanoelectronic detection, which supports our primary business focus," said David Macdonald, President and CEO of Nanomix. "These advancements open up a wide range of applications and commercial opportunities. As the first company to bring a nanoelectronic product to market, we are excited to be at the leading edge of this promising industry. In addition to our own products, we are currently pursuing a number of collaborations for the commercial deployment of Sensation technology."
This patent (US Patent No. 6,894,359, issued May 17, 2005) is the first to be issued in Nanomix' growing portfolio of pending patent applications for the Sensation detection platform and its industrial and biomedical uses. This follows the issuance of three previous patents related to Nanomix' hydrogen storage technology.
Nanomix is a leading nanotechnology company launching a menu of devices based on Sensation™ detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistry and silicon. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanotechnology - low power consumption, small size, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information.
Toll Free: 877.Nanomix (877.626.6649)
Copyright © Nanomix
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
New Nanopore Sensor Simplifies Analysis of Methylated DNA May 20th, 2013
Advancements and developments of solid-state nanopores sensors May 16th, 2013
Imec and Renesas collaborate on ultra-low power short range radios: Collaboration will develop robust wireless solutions for future electronics May 16th, 2013
Physicists discover a new kind of friction: Friction in the nano-world May 16th, 2013
Competition in the Quantum World May 20th, 2013
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Penn engineers' nanoantennas improve infrared sensing May 20th, 2013
Researchers Perform Fastest Measurements Ever Made of Ion Channel Proteins May 20th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone May 7th, 2013